Jun 15, 2023, 16:06
55% complete response rate by 4th gen CART19 -huIL18 in CAR-19 relapsed lymphomas
In a post by Jonathan Schatz on Twitter, it says, “55% complete response rate by 4th gen CART19 -huIL18 in CAR-19 relapsed lymphomas. Intriguing early data International Conference on Malignant Lymphoma.”
Source: Jonathan Schatz/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21